Skip to main content
Caplight Logo









Hedia

Hedia

Private
CopenhagenHealthcare & Life Scienceshttps://www.hedia.com/

Last Round

Seed

Feb 27, 2024

Total Funding Raised

$10.94M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Hedia is a digital therapeutics company that provides a personal diabetes assistant application to help patients manage insulin-requiring diabetes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement, Medical AI

Business Model

B2B2C

Customer Profile

Subscription SaaS, Freemium, Data as a Service

AI Layer

Application

Keywords

diabetes managementdigital therapeuticsDTxdiabetes appbolus calculatorinsulin calculatorsoftware as a medical deviceSaMDAI medical deviceclinical decision supportchronic disease managementmobile healthmHealthCGM integrationsmart insulin pen integrationsubscription SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hedia Comparables

Compare Hedia with similar companies based on industry and business-model similarity.

Hedia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DiappyMed
84%
SocialDiabetes
83%
Insulcloud S.L.
78%

Hedia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 27, 2024
SeedDec 23, 2021
SeedNov 10, 2020
GrantNov 10, 2020
VC RoundJul 1, 2019
Seed
Jul 1, 2017

Key People

Founding team and executive leadership

Andreas Jespensgaard

Co-Founder, Chief Design Officer

Founding Team

Rasmus Kofoed

CEO

Executive Team

Niklas Karre-Gundlev

Chief Technology Officer

Executive Team

Christian Bent Rode

CFO

Executive Team

Hedia Investors

Notable investors and investment history

Hedia investors
InvestorRounds
European Innovation Council FundGrant, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 13, 2026

    Monthly visitors grew 103% MoM.

  • Aug 21, 2026

    Monthly visitors grew 68% MoM.

Recent news

Latest coverage and updates

  • is_developingSep 22, 2026

    Hedia ApS is developing digital therapeutic solutions on Jul 1st '16.

Hedia Filings

Explore SEC and related filing metadata, where available.

Hedia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hedia's valuation, stock price, and market status.

Is Hedia a public or private company?

Hedia is a private company.

What is the current stock price of Hedia?

Hedia is a private company, so its shares have no public market price. Caplight tracks Hedia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Hedia worth (valuation)?

Valuation information for Hedia is not publicly available.

Can I buy Hedia stock?

Hedia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Hedia's last funding round?

Hedia's most recent funding round was Seed on February 27, 2024.

Who are the main investors in Hedia?

Key investors in Hedia include European Innovation Council Fund.

Will Hedia IPO soon?

No public IPO plans have been announced for Hedia.

How can I track Hedia secondary market activity?

Caplight tracks bids, offers, and trades in Hedia's shares on secondary markets.

Firmographic Details

HeadquartersCopenhagen
Employee Range24
Year Founded2016
Last FundingFeb 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?